跳至主要内容
临床试验/ISRCTN96891086
ISRCTN96891086已完成不适用

Artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated malaria treatment in children with or without sickle cell disease: a randomized efficacy and safety trial

Danida Fellowship Centre (Denmark)0 个研究点目标入组 120 人开始时间: 2013年10月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Children with SCD
  • 2. Aged 6 months to 12 years
  • 3. With acute P. falciparum malaria of parasite density < 200,000/µl
  • 4. Consent obtained and willingness by parent or guardian to comply with the follow-up schedule

排除标准

  • 1. Symptoms or signs of severe malaria requiring parenteral treatment
  • 2. Weight less than 5 kg
  • 3. Presence of danger signs of malaria
  • 4. Known intolerance or allergy to study medications
  • 5. Reported treatment with any of the study drugs one month preceding enrolment
  • 6. Blood transfusion preceding 3 months before enrolment

研究者

发起方
Danida Fellowship Centre (Denmark)

相似试验